Division of Vascular Surgery

Clinical Trials NOW ENROLLING

11931-02: Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects with Moderate or High-Risk Critical Limb Ischemia. 

550602  Clinical Evaluation of Efficacy and Safety of FS VH S/D 500 S-APR for Hemostasis in Subjects Undergoing Vascular Surgery   

TAMARIS - Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions

Clinical trials are closely monitored research studies of new treatments - investigational drugs or medical devices - administered to human beings.  Clinical trials rely on the participation of patients who volunteer to try new or modified treatments. Clinical trials help scientists determine the safety and effectiveness of new therapies.  Together, the patient, the patient's physician, and those who administer clinical trials decide whether a patient is eligible to participate in a specific study.

Each clinical trial looks for patients with a specific type of condition or disease. All patients treated in a particular clinical trial, in general, must:

• Have your condition diagnosed and evaluated.
• Have your general health status reviewed by a licensed medical professional.
• Have all of your treatment-related and clinical trial questions answered to your satisfaction.
• Give your informed consent, which means that you understand the possible risks and benefits of participating in a clinical trial.

More Information

This posting is a summary of the basic requirements for participation in this study, and it is not intended to provide all the information needed to decide whether or not to participate.

For additional information, please contact the study coordinator at the phone number listed below.

Maria Maloney, MPA - Research Associate    

Direct phone 801-585-3663  

Direct FAX 801-581-3433   

e-mail: maria.maloney@hsc.utah.edu